לברסט

देश: इसराइल

भाषा: हिब्रू

स्रोत: Ministry of Health

सक्रिय संघटक:

LETROZOLE 2.5 MG

थमां उपलब्ध:

RAFA LABORATORIES LTD

ए.टी.सी कोड:

L02BG04

फार्मास्यूटिकल फॉर्म:

FILM COATED TABLETS

प्रशासन का मार्ग:

PER OS

द्वारा बनाया गया:

SIEGFRIED GENERICS ( MALTA) LTD

चिकित्सीय समूह:

LETROZOLE

चिकित्सीय संकेत:

Letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

प्राधिकरण की तारीख:

2012-04-01